OsoBio President Milton Boyer Appointed to DCAT Executive Committee

Albuquerque, NM Nov 8, 2012 – Milton Boyer, president of OsoBio, has been appointed to the executive committee of the Drug, Chemical and Associated Technologies Association (DCAT).
Boyer – whose term began Nov. 1 – will represent the contract formulation, fill, finish, and contract packaging industry as segment vice president. Boyer joined the DCAT board of directors last year.
Founded in 1891, DCAT is the premier business development association whose membership consists of companies that manufacture, distribute or provide services to the pharmaceutical, chemical and related industries. More than 300 corporate members belong to DCAT.
“DCAT is one of the most unique trade organizations in our industry. Because it is truly member-run, each individual has an opportunity to make a distinctive impact, and new initiatives continue to increase the organization’s value proposition,” Boyer said. “I am honored to be selected for this position by my industry peers and look forward to serving in my new role.”
In addition to his board membership at DCAT, Boyer is a member of the International Society of Pharmaceutical Engineers (ISPE) and the American Association of Pharmaceutical Scientists (AAPS).
OSO BioPharmaceuticals Manufacturing LLC – OsoBio for short – is a contract manufacturing organization (CMO) that specializes in delivering injectable sterile liquid, suspension and lyophilized biologic and pharmaceutical products to the pharmaceutical industry. The company offers significant knowledge and experience in late-phase clinical products and successfully taking them to commercialization.
In the history of its Albuquerque, N.M., facility, OsoBio has manufactured more than 250 distinct commercial presentations in every major therapeutic category. The U.S. Drug Enforcement Administration (DEA) has granted OsoBio registrations for Schedule II through V controlled substances.